The Global Health Body Issues Warning Over Critical Scarcity of Obesity Medications

Under 10% of people who could benefit from weight-loss injections including Wegovy have access to them, states the global health agency as it releases its first guidance on the medications.

Given more than one billion individuals worldwide currently obese, it is urging more widespread and fairer availability to GLP-1 medication.

Based on projections, in excess of 2,000,000,000 will be living with obesity by 2030 without intervention.

"Our latest guidelines recognises that obesity is a long-term condition that can be managed with holistic and lifelong support," remarked its chief Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and logistical bottlenecks are significant obstacles to universal availability to the jabs that can assist patients in reducing considerable body mass, says the body.

Weight-Loss Drug Scarcity

Even in the present most optimistic outlook, the production of GLP-1 therapies would only suffice for around 100 million people – fewer than 10% of eligible patients, according to the WHO.

The recommendation encourages countries and companies to expand availability, by approaches like voluntary licensing.

Exclusive production rights on the active ingredient – the core component of the drug Wegovy – is scheduled to end in a number of countries in 2026.

The Way Weight-Loss Jabs Work

GLP-1 drugs mimick a natural hormone to delay gastric emptying, suppress the appetite and increase satiety so people reduce food intake.

Individuals commonly see weight reduction after several weeks of beginning the weekly injections.

Studies suggests users may regain a significant portion after a year of halting the medication, when their normal appetite return.

To be overweight or obese increases your chance for experiencing medical conditions, including diabetes, cardiovascular issues, stroke, and certain malignancies.

Obesity affects people in countries worldwide and was responsible for over three and a half million fatalities worldwide in 2024, according to the health agency.

David Ayala
David Ayala

Elena Vargas es una periodista independiente con más de una década de experiencia en reportajes internacionales y análisis político.